Immunostimulatory DNA as a vaccine adjuvant (Q36968274)

17 August 2017

1 reference

title

Immunostimulatory DNA as a vaccine adjuvant (English)

1 reference

17 August 2017

Debbie Higgins

1

1 reference

17 August 2017

Jason D Marshall

2

1 reference

17 August 2017

Paula Traquina

3

1 reference

17 August 2017

Gary Van Nest

4

1 reference

17 August 2017

Brian D Livingston

5

1 reference

17 August 2017

1 October 2007

1 reference

Expert Review of Vaccines

17 August 2017

1 reference

17 August 2017

6

1 reference

17 August 2017

5

1 reference

17 August 2017

747-759

1 reference

Cooperation of Toll-like receptor signals in innate immune defence

17 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

TLR9 signals after translocating from the ER to CpG DNA in the lysosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Plasmacytoid dendritic cells: the key to CpG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Activation of NK cell (human and mouse) by immunostimulatory DNA sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Novel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Potent CpG oligonucleotides containing phosphodiester linkages: in vitro and in vivo immunostimulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Activation of human B cells by phosphorothioate oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Comparative Analysis of Anti-Hepatitis C Virus Activity and Gene Expression Mediated by Alpha, Beta, and Gamma Interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Stimulation of type I IFN activity in Atlantic salmon (Salmo salar L.) leukocytes: synergistic effects of cationic proteins and CpG ODN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Binding immune-stimulating oligonucleotides to cationic peptides from viral core antigen enhances their potency as adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Novel treatments for food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

A review of CpGs and their relevance to aquaculture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Biological activity of immunostimulatory CpG DNA motifs in domestic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Neonatal and early life vaccinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Immunosenescence and infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Resistance to influenza A virus infection by antigen-conjugated CpG oligonucleotides, a novel antigen-specific immunomodulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

A universal vaccine for serogroup B meningococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Synthetic oligonucleotides: the development of antisense therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Interferon-gamma mediates suppression of erythropoiesis but not reduced red cell survival following CpG-ODN administration in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Pyrogenicity of CpG-DNA in mice: role of interleukin-6, cyclooxygenases, and nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Safety and efficacy of CpG-containing oligodeoxynucleotides as immunological adjuvants in rabbits*1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

TLR9-Dependent Recognition of MCMV by IPC and DC Generates Coordinated Cytokine Responses that Activate Antiviral NK Cell Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.747

21 January 2018

Identifiers

DOI

10.1586/14760584.6.5.747

1 reference

release_cbkawmxaijgplhyvzezuvoldea

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cbkawmxaijgplhyvzezuvoldea

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference